These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 9218626)
21. Role of the Sm antigen in the generation of anti-Sm autoantibodies in the SLE-prone MRL mouse. Shores EW; Eisenberg RA; Cohen PL J Immunol; 1986 May; 136(10):3662-7. PubMed ID: 3701058 [TBL] [Abstract][Full Text] [Related]
22. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival. Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922 [TBL] [Abstract][Full Text] [Related]
24. Antigen-specific T-cell hyporesponsiveness in MRL congenic mice can be explained by two independent cellular defects. Waterfield JD; Fairhurst M; Chu R; Levy JG Immunology; 1987 Jun; 61(2):173-8. PubMed ID: 2954899 [TBL] [Abstract][Full Text] [Related]
25. MHC genes modify systemic autoimmune disease. The role of the I-E locus. Creech EA; Nakul-Aquaronne D; Reap EA; Cheek RL; Wolthusen PA; Cohen PL; Eisenberg RA J Immunol; 1996 Jan; 156(2):812-7. PubMed ID: 8543837 [TBL] [Abstract][Full Text] [Related]
26. Influence of the Ig H chain locus on autoantibody production in autoimmune mice. Halpern MD; Fisher CL; Cohen PL; Eisenberg RA J Immunol; 1992 Dec; 149(11):3735-40. PubMed ID: 1431145 [TBL] [Abstract][Full Text] [Related]
27. Anti-nRNP anti-nuclear antibody-secreting cells are represented in the B-lymphocyte repertoire of normal and MRL/MP-lpr/lpr lupus mice. Brennan FM; Andrew EM; Williams DG; Maini RN Immunology; 1988 Feb; 63(2):213-7. PubMed ID: 3258271 [TBL] [Abstract][Full Text] [Related]
28. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011 [TBL] [Abstract][Full Text] [Related]
29. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies. Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978 [TBL] [Abstract][Full Text] [Related]
30. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. Chan O; Shlomchik MJ J Immunol; 1998 Jan; 160(1):51-9. PubMed ID: 9551955 [TBL] [Abstract][Full Text] [Related]
31. Development of the autoimmune B cell repertoire in MRL-lpr/lpr mice. Klinman DM; Eisenberg RA; Steinberg AD J Immunol; 1990 Jan; 144(2):506-11. PubMed ID: 2295800 [TBL] [Abstract][Full Text] [Related]
32. Defects in the regulation of B cell apoptosis are required for the production of citrullinated peptide autoantibodies in mice. López-Hoyos M; Marquina R; Tamayo E; González-Rojas J; Izui S; Merino R; Merino J Arthritis Rheum; 2003 Aug; 48(8):2353-61. PubMed ID: 12905491 [TBL] [Abstract][Full Text] [Related]
33. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease. Dobashi K; Ono S; Murakami S; Takahama Y; Katoh Y; Hamaoka T J Immunol; 1987 Feb; 138(3):780-7. PubMed ID: 3543118 [TBL] [Abstract][Full Text] [Related]
34. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype. Prud'Homme GJ; Park CL; Fieser TM; Kofler R; Dixon FJ; Theofilopoulos AN J Exp Med; 1983 Feb; 157(2):730-42. PubMed ID: 6600490 [TBL] [Abstract][Full Text] [Related]
35. Different expression of T-cell receptor beta-chain variable region genes in lymph nodes of lpr mice with different alleles of the major histocompatibility complex. Ohga S; Yoshikai Y; Kishihara K; Matsuzaki G; Ogimoto M; Nomoto K Immunology; 1990 Jun; 70(2):216-22. PubMed ID: 2373519 [TBL] [Abstract][Full Text] [Related]
36. Expression and function of Fas on cells damaged by gamma-irradiation in B6 and B6/lpr mice. Booker JK; Reap EA; Cohen PL J Immunol; 1998 Nov; 161(9):4536-41. PubMed ID: 9794379 [TBL] [Abstract][Full Text] [Related]
37. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice. Song YC; Tang SJ; Lee TP; Hung WC; Lin SC; Tsai CY; Ng WV; Wu MF; Sun KH Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162 [TBL] [Abstract][Full Text] [Related]
38. CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production. Mountz JD; Smith HR; Wilder RL; Reeves JP; Steinberg AD J Immunol; 1987 Jan; 138(1):157-63. PubMed ID: 3537128 [TBL] [Abstract][Full Text] [Related]
39. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. Chan OT; Madaio MP; Shlomchik MJ J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951 [TBL] [Abstract][Full Text] [Related]
40. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses. Ma J; Xu J; Madaio MP; Peng Q; Zhang J; Grewal IS; Flavell RA; Craft J J Immunol; 1996 Jul; 157(1):417-26. PubMed ID: 8683147 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]